Cover Image
市場調查報告書

血液分析設備的全球市場:醫療設備的開發平台評估

Haematology Analyzers - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 365826
出版日期 內容資訊 英文 113 Pages
訂單完成後即時交付
價格
Back to Top
血液分析設備的全球市場:醫療設備的開發平台評估 Haematology Analyzers - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年08月01日 內容資訊: 英文 113 Pages
簡介

本報告提供全球血液分析設備的市場上,的主要開發中產品與臨床實驗的進展調查,產品的功能、特性比較分析 (臨床實驗的各進展階段) ,再加上主要企業簡介及代表性產品,近來的市場動靜 (業績報告、資本交易趨勢等) 的資訊彙整,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 血液分析設備概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期

第4章 臨床實驗中的開發中產品:各企業

  • 血液分析設備的企業:各臨床實驗階段的開發中產品
  • 血液分析設備:各臨床實驗階段的開發中產品

第5章 血液分析設備市場:企業、產品概要

  • Abbott Diagnostics
    • 開發中產品及進行中的臨床實驗概要
  • Analyticon Biotechnologies AG
  • Apollo Medical Devices LLC
  • Arkray, Inc.
  • Auer Precision
  • Axxin Company
  • Baebies, Inc.
  • Columbia University
  • DiaSorin S.p.A
  • Diatron Medical Instruments Limited
  • Drew Scientific Co. Limited
  • Ionu Biosystems
  • IRIS International, Inc.
  • Mindray Medical International Limited
  • Noninvasix, Inc.
  • Quotient Limited
  • Roche Diagnostics International Ltd.
  • SigTuple Technologies Private Limited
  • SpinChip Diagnostics AS
  • Sysmex
  • T2. Biosystems, Inc.
  • Tarabios
  • The University of British Columbia
  • University of Barcelona
  • Visca Corporation

第6章 血液分析設備市場:目前的趨勢 (共67件)

第7章 附錄

圖表一覽

目錄
Product Code: GDME0214EPD

GlobalData's Medical Devices sector report, "Haematology Analyzers - Medical Devices Pipeline Assessment, 2016" provides an overview of Haematology Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Haematology Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Haematology Analyzers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Haematology Analyzers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Haematology Analyzers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Haematology Analyzers Overview

3. Products under Development

  • 3.1. Haematology Analyzers - Pipeline Products by Stage of Development
  • 3.2. Haematology Analyzers - Pipeline Products by Territory
  • 3.3. Haematology Analyzers - Pipeline Products by Regulatory Path
  • 3.4. Haematology Analyzers - Pipeline Products by Estimated Approval Date

4. Haematology Analyzers - Pipeline Products under Development by Companies

  • 4.1. Haematology Analyzers Companies - Pipeline Products by Stage of Development
  • 4.2. Haematology Analyzers - Pipeline Products by Stage of Development

5. Haematology Analyzers Companies and Product Overview

  • 5.1. Abbott Diagnostics Company Overview
    • 5.1.1. Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Analyticon Biotechnologies AG Company Overview
    • 5.2.1. Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Apollo Medical Devices LLC Company Overview
    • 5.3.1. Apollo Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Arkray, Inc. Company Overview
    • 5.4.1. Arkray, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Auer Precision Company Overview
    • 5.5.1. Auer Precision Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Axxin Company Overview
    • 5.6.1. Axxin Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Baebies, Inc. Company Overview
    • 5.7.1. Baebies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Columbia University Company Overview
    • 5.8.1. Columbia University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. DiaSorin S.p.A Company Overview
    • 5.9.1. DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Diatron Medical Instruments Limited Company Overview
    • 5.10.1. Diatron Medical Instruments Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Drew Scientific Co. Limited Company Overview
    • 5.11.1. Drew Scientific Co. Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Ionu Biosystems Company Overview
    • 5.12.1. Ionu Biosystems Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. IRIS International, Inc. Company Overview
    • 5.13.1. IRIS International, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Mindray Medical International Limited Company Overview
    • 5.14.1. Mindray Medical International Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Noninvasix, Inc. Company Overview
    • 5.15.1. Noninvasix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Quotient Limited Company Overview
    • 5.16.1. Quotient Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Roche Diagnostics International Ltd. Company Overview
    • 5.17.1. Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. SigTuple Technologies Private Limited Company Overview
    • 5.18.1. SigTuple Technologies Private Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. SpinChip Diagnostics AS Company Overview
    • 5.19.1. SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Sysmex Corporation Company Overview
    • 5.20.1. Sysmex Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. T2. Biosystems, Inc. Company Overview
    • 5.21.1. T2. Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Tarabios Company Overview
    • 5.22.1. Tarabios Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. The University of British Columbia Company Overview
    • 5.23.1. The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. University of Barcelona Company Overview
    • 5.24.1. University of Barcelona Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. Visca Corporation Company Overview
    • 5.25.1. Visca Corporation Pipeline Products & Ongoing Clinical Trials Overview

6. Haematology Analyzers- Recent Developments

  • 6.1. Jul 16, 2016: Alere initiating voluntary withdrawal of Alere INRatio and INRatio 2 PT/INR Monitoring System that may pose serious health risks
  • 6.2. Jul 15, 2016: CellaVision: Interim Report January-June 2016
  • 6.3. Jul 11, 2016: Quotient Provides Update on the MosaiQ Development Plan
  • 6.4. Jul 11, 2016: Quotient Reports Preliminary Fiscal First Quarter 2017 Revenues
  • 6.5. Jul 11, 2016: EKF Diagnostics Holdings Appoints Carl Dominic Contadini As Non-Executive Director
  • 6.6. Jul 08, 2016: Reed Construction Selected To Complete New Medline Headquarters
  • 6.7. Jun 28, 2016: InDevR Appoints Dawn Bitz as Chief Commercial Officer
  • 6.8. Jun 27, 2016: Medline and Medic Management Group Launch New GPO Distribution Partnership
  • 6.9. Jun 24, 2016: Genome British Columbia Investing in Companies and Jobs Through e@UBC
  • 6.10. Jun 23, 2016: ORTHO VISION Analyzer Named Innovation Celebration Award Winner at Premier's Annual Meeting
  • 6.11. Jun 21, 2016: MiMedx Reaches Settlement With Medline Industries And Liventa Bioscience For Certain Claims
  • 6.12. Jun 20, 2016: Sysmex Canada to Distribute CellaVision Systems
  • 6.13. Jun 17, 2016: Daxor Announces Hiring of Chief Financial Officer
  • 6.14. Jun 15, 2016: Siemens Healthcare Becomes Siemens Healthineers
  • 6.15. Jun 13, 2016: EKF Diagnostics' Quo-Test HbA1c analyzer achieves class leading level of performance
  • 6.16. Jun 01, 2016: Invetech, Haemonetics, and Coramed Technologies Receive 2016 Good Design Award for Development of the TEG 6s
  • 6.17. May 31, 2016: ERBA Diagnostics Announces Extension of CEO'S Contract Term and Appointment of Hayden Jeffreys to Board of Directors
  • 6.18. May 23, 2016: New Distribution Partnership for Edward-Elmhurst Health's Physician Offices Results in Cost Savings of 10 Percent
  • 6.19. May 23, 2016: Quotient Reports Continued Progress on the Development of MosaiQ and Fourth Quarter and Fiscal Year 2016 Financial Results
  • 6.20. May 20, 2016: ERBA Diagnostics Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards and Extension of Compliance Plan
  • 6.21. May 19, 2016: Medline Inks Three-Year Prime Vendor Distribution Agreement with SBH Health System
  • 6.22. May 16, 2016: Escalon Medical Reports Third Quarter Fiscal 2016 Results
  • 6.23. May 09, 2016: EKF Diagnostics Announces Directorate Change
  • 6.24. May 09, 2016: Haemonetics Provides Fiscal 2017 Guidance
  • 6.25. May 09, 2016: Haemonetics Announces Christopher Simon as President and Chief Executive Officer
  • 6.26. Apr 28, 2016: Ortho Clinical Diagnostics Announces Availability of ORTHO Sera Extended Phenotype Testing on ORTHO VISION Analyzer for BioVue Cassettes
  • 6.27. Apr 28, 2016: Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2016
  • 6.28. Apr 28, 2016: Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2016 and Declares a 9% Increase in Quarterly Cash Dividend
  • 6.29. Apr 26, 2016: MD Anderson Cancer Center to acquire Elekta linear accelerators and other radiotherapy solutions
  • 6.30. Apr 20, 2016: EKF Diagnostics Holdings Announces Directorate Change
  • 6.31. Apr 13, 2016: Quotient Announces Positive MosaiQ Serological Disease Screening Results
  • 6.32. Apr 06, 2016: Real-World Impact on Heart Failure Mortality and Readmissions of Individualized Care Guided by Blood Volume Analysis: New Data Presented at the American College of Cardiology Congress
  • 6.33. Mar 24, 2016: Baron & Budd Investigating Claims Involving the Alere INRatio Blood-Testing System
  • 6.34. Mar 23, 2016: STRATEC Biomedical to Acquire Diatron from Riverside Company
  • 6.35. Mar 09, 2016: University of Hawaii and The Queen's Medical Center Reports on a Study on Critically Ill Patients Utilizing Blood Volume Measurement and Pulmonary Artery Catheterization
  • 6.36. Mar 01, 2016: HORIBA: Alliance'2016
  • 6.37. Feb 29, 2016: Daxor Corporation Announces Upcoming Filing of Form N-CSR for December 31, 2015 and Recent Developments
  • 6.38. Feb 22, 2016: Sysmex America Enters into Distribution Agreement with Medline Industries
  • 6.39. Feb 16, 2016: Escalon Medical Reports Second Quarter Fiscal 2016 Results
  • 6.40. Feb 09, 2016: HORIBA Formulates New Mid-Long Term Management Plan MLMAP2020
  • 6.41. Feb 08, 2016: Daxor Announces Sale of BVA-100 Blood Volume Analyzer to Nebraska Medicine
  • 6.42. Feb 08, 2016: Quotient Reports Third Quarter Fiscal 2016 Financial Results
  • 6.43. Jan 28, 2016: Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2016, Declares Quarterly Cash Dividend
  • 6.44. Jan 11, 2016: Quotient Announces Positive Serological Disease Screening Results and Provides MosaiQ Development Program Update
  • 6.45. Dec 10, 2015: Daxor Announces an Increased Dividend and the Appointment of Michael Feldschuh as President and Chief Executive Officer on a Temporary Basis
  • 6.46. Dec 01, 2015: Sysmex Establishes New Subsidiary in Ghana - Reinforcing the Company's Business Foundation in the Markets of West and Central Africa
  • 6.47. Nov 16, 2015: Escalon Medical Reports First Quarter Fiscal 2016 Results
  • 6.48. Nov 13, 2015: Mindray Announces Third Quarter 2015 Financial Results
  • 6.49. Nov 12, 2015: Terre Haute Regional Hospital Becomes First to Install the Ortho Clinical Diagnostics Ortho Vision Analyzer
  • 6.50. Oct 27, 2015: Abaxis Reports Financial Performance for the Second Quarter of Fiscal 2016
  • 6.51. Oct 22, 2015: Trinity Biotech announces Quarter 3 Financial Results
  • 6.52. Oct 14, 2015: Ortho Clinical Diagnostics Receives CE Mark Clearance for ORTHO VISION Max Analyzer for High-Volume Transfusion Medicine Labs
  • 6.53. Oct 02, 2015: Heart Failure Research from the Mayo Clinic Utilizing the BVA-100 Blood Volume Analyzer presented at the Annual Heart Failure Society of America Meeting
  • 6.54. Oct 01, 2015: David Pacitti to Lead Siemens Healthcare North America Regional Organization
  • 6.55. Sep 28, 2015: Escalon Medical Reports Fiscal 2015 Results
  • 6.56. Sep 24, 2015: Diatron to introduce a revolutionary approach to hematology analysis at Medica 2015
  • 6.57. Sep 15, 2015: Sysmex to Expand U.S. Reagent Factory - Aiming to Meet Growing Demand in the Americas
  • 6.58. Sep 07, 2015: Transasia Bio-Medicals Plans to Raise Funds through IPO
  • 6.59. Aug 28, 2015: Precision System Science to Raise USD11 Million in Public Offering of Shares
  • 6.60. Aug 28, 2015: Precision System Science to Raise USD1.5 Million in Private Placement of Shares
  • 6.61. Aug 18, 2015: Ortho Clinical Diagnostics Receives 510(k) Clearance for ORTHO VISION Analyzer, Making it Commercially Available in the United States
  • 6.62. Aug 18, 2015: Ortho Clinical Diagnostics Selects Model N for Global Deployment of Revvy Configure Price Quote for Medical Technologies
  • 6.63. Aug 10, 2015: Mindray Announces Second Quarter 2015 Financial Results
  • 6.64. Aug 03, 2015: Bio-Rad Introduces the IH-500, a Fully Automated Random Access System for Blood Typing and Screening
  • 6.65. Aug 03, 2015: Ortho Clinical Diagnostics Appoints Kristie Bouryal Chief Corporate Brand and Communications Officer
  • 6.66. Jul 31, 2015: Tokuyama Announces Consolidated Results For Q1 FY2015
  • 6.67. Jul 30, 2015: Mindray's Latest IVD Inventions Showcased at AACC 2015

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Haematology Analyzers - Pipeline Products by Stage of Development
  • Table 2: Haematology Analyzers - Pipeline Products by Territory
  • Table 3: Haematology Analyzers - Pipeline Products by Regulatory Path
  • Table 4: Haematology Analyzers - Pipeline Products by Estimated Approval Date
  • Table 5: Haematology Analyzers Companies - Pipeline Products by Stage of Development
  • Table 6: Haematology Analyzers - Pipeline Products by Stage of Development
  • Table 7: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: Next Generation Hematology Analyzer - Product Status
  • Table 9: Next Generation Hematology Analyzer - Product Description
  • Table 10: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 11: Hemolyzer 3 Pro - Product Status
  • Table 12: Hemolyzer 3 Pro - Product Description
  • Table 13: Hemolyzer 5 - Product Status
  • Table 14: Hemolyzer 5 - Product Description
  • Table 15: Apollo Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: Point-Of-Care Blood Analyzer - Product Status
  • Table 17: Point-Of-Care Blood Analyzer - Product Description
  • Table 18: Arkray, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: ADAMS A1c Lite HA-8380V - Product Status
  • Table 20: ADAMS A1c Lite HA-8380V - Product Description
  • Table 21: Auer Precision Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: Blood Separation Microfluidic Device - Product Status
  • Table 23: Blood Separation Microfluidic Device - Product Description
  • Table 24: Axxin Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: Burnet AX-2 CD4 Test Reader - Product Status
  • Table 26: Burnet AX-2 CD4 Test Reader - Product Description
  • Table 27: Baebies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: FINDER - Product Status
  • Table 29: FINDER - Product Description
  • Table 30: Columbia University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: Microfluidic Device - Coagulation Dysfunction - Product Status
  • Table 32: Microfluidic Device - Coagulation Dysfunction - Product Description
  • Table 33: DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: LIAISON IAM - Product Status
  • Table 35: LIAISON IAM - Product Description
  • Table 36: Diatron Medical Instruments Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: 3-part Differential Hematology Analyzer - Product Status
  • Table 38: 3-part Differential Hematology Analyzer - Product Description
  • Table 39: Drew Scientific Co. Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 40: DS360 HbA1c Analyzer - Product Status
  • Table 41: DS360 HbA1c Analyzer - Product Description
  • Table 42: Ionu Biosystems Pipeline Products & Ongoing Clinical Trials Overview
  • Table 43: Fluorescent Smart Phone Blood Analyzer - Product Status
  • Table 44: Fluorescent Smart Phone Blood Analyzer - Product Description
  • Table 45: IRIS International, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: 3GEMS Hematology Analyzer - Product Status
  • Table 47: 3GEMS Hematology Analyzer - Product Description
  • Table 48: Mindray Medical International Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: BC-20s - Product Status
  • Table 50: BC-20s - Product Description
  • Table 51: BC-30s - Product Status
  • Table 52: BC-30s - Product Description
  • Table 53: BC-5000 Hematology Analyzer - Product Status
  • Table 54: BC-5000 Hematology Analyzer - Product Description
  • Table 55: Noninvasix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: Optoacoustic-Based Non-Invasive Blood Diagnostic Device - Product Status
  • Table 57: Optoacoustic-Based Non-Invasive Blood Diagnostic Device - Product Description
  • Table 58: Quotient Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: MosaiQ - Product Status
  • Table 60: MosaiQ - Product Description
  • Table 61: Quant-Rho For Cell Analyzer - Product Status
  • Table 62: Quant-Rho For Cell Analyzer - Product Description
  • Table 63: Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 64: cobas m 511 - Bloodhound System - Product Status
  • Table 65: cobas m 511 - Bloodhound System - Product Description
  • Table 66: Cobas m511 System - Product Status
  • Table 67: Cobas m511 System - Product Description
  • Table 68: SigTuple Technologies Private Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 69: Shonit - Product Status
  • Table 70: Shonit - Product Description
  • Table 71: SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview
  • Table 72: SpinChip - Product Status
  • Table 73: SpinChip - Product Description
  • Table 74: Sysmex Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 75: Liquid Biopsy System - Product Status
  • Table 76: Liquid Biopsy System - Product Description
  • Table 77: T2 Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 78: T2Plex - Product Status
  • Table 79: T2Plex - Product Description
  • Table 80: Tarabios Pipeline Products & Ongoing Clinical Trials Overview
  • Table 81: Benchtop System - Blood Screen - Product Status
  • Table 82: Benchtop System - Blood Screen - Product Description
  • Table 83: The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
  • Table 84: Portable Hematology Analyzer - Product Status
  • Table 85: Portable Hematology Analyzer - Product Description
  • Table 86: University of Barcelona Pipeline Products & Ongoing Clinical Trials Overview
  • Table 87: Micro - rheometer - Product Status
  • Table 88: Micro - rheometer - Product Description
  • Table 89: Visca Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 90: Visca Device - Product Status
  • Table 91: Visca Device - Product Description
  • Table 92: Glossary

List of Figures

  • Figure 1: Haematology Analyzers - Pipeline Products by Stage of Development
  • Figure 2: Haematology Analyzers - Pipeline Products by Territory
  • Figure 3: Haematology Analyzers - Pipeline Products by Regulatory Path
  • Figure 4: Haematology Analyzers - Pipeline Products by Estimated Approval Date
Back to Top